These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30626937)

  • 1. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
    Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
    Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3.
    Lu YJ; Deng YT; Ko HH; Peng HH; Lee HC; Kuo MY; Cheng SJ
    Cancer Sci; 2023 Oct; 114(10):3957-3971. PubMed ID: 37496288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma.
    Zhou L; Le K; Chen Q; Wang H
    BMC Oral Health; 2024 Aug; 24(1):898. PubMed ID: 39107736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis.
    Sinto MS; Thomas S; Kannan S
    Med Oncol; 2021 Aug; 38(9):110. PubMed ID: 34357463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
    PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
    de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
    Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma.
    Yin P; Cui S; Liao X; Yao X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
    Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
    J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
    Huang Z; Rui X; Yi C; Chen Y; Chen R; Liang Y; Wang Y; Yao W; Xu X; Huang Z
    J Exp Clin Cancer Res; 2023 Mar; 42(1):60. PubMed ID: 36899380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
    Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
    Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells by Regulating ERK/ELK-1/Snail Signaling.
    Huang Y; Li F
    Discov Med; 2024 Jun; 36(185):1298-1305. PubMed ID: 38926116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.